Patents/Assignees

SPRINGWORKS THERAPEUTICS, Inc.

37 patents in portfolio

US12011435utility2024
Treatments with Nirogacestat
0 cites
US11957662utility2024
Treatments with Nirogacestat
0 cites
US11951096utility2024
Treatments with Nirogacestat
0 cites
US11938116utility2024
Treatments with Nirogacestat
0 cites
US11925619utility2024
Treatments with Nirogacestat
0 cites
US11925620utility2024
Treatments with Nirogacestat
0 cites
US11883375utility2024
Mirdametinib Treatment
0 cites
US11884610utility2024
Crystalline Solids of Mek Inhibitor N-((r)-2,3-dihydroxypropoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and Uses Thereof
0 cites
US11872211utility2024
Treatments with Nirogacestat
0 cites
US11844780utility2023
Chlorinated Tetralin Compounds and Pharmaceutical Compositions
0 cites
US11839595utility2023
Mirdametinib Treatment
0 cites
US11819487utility2023
Treatment of Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN) in Pediatric Patients with Mirdametinib
0 cites
US11806321utility2023
Non-linear Dosing of Mirdametinib
0 cites
US11806322utility2023
Mirdametinib Treatment
0 cites
US11807611utility2023
Chlorinated Tetralin Compounds and Pharmaceutical Compositions
0 cites
US11780800utility2023
Fluorinated Phenylamino Compounds and Pharmaceutical Compositions
0 cites
US11571402utility2023
Dispersible Formulations of N-((r)-2,3-dihydroxypropoly)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide and Uses Thereof
0 cites

← PreviousPage 2 of 2